Microbot Medical Inc. (NASDAQ:MBOT - Get Free Report) saw some unusual options trading activity on Tuesday. Investors bought 4,407 call options on the company. This is an increase of 246% compared to the average volume of 1,272 call options.
Microbot Medical Price Performance
NASDAQ:MBOT traded down $0.05 during trading hours on Friday, reaching $2.60. 852,258 shares of the company were exchanged, compared to its average volume of 1,782,981. The firm has a market cap of $94.40 million, a price-to-earnings ratio of -4.02 and a beta of 1.13. Microbot Medical has a 52-week low of $0.82 and a 52-week high of $3.38. The stock has a 50 day simple moving average of $2.55 and a 200 day simple moving average of $2.06.
Microbot Medical (NASDAQ:MBOT - Get Free Report) last released its quarterly earnings results on Wednesday, May 21st. The biotechnology company reported ($0.08) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.07. On average, analysts predict that Microbot Medical will post -0.71 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of MBOT. Virtu Financial LLC acquired a new position in Microbot Medical during the 1st quarter valued at about $42,000. Goldman Sachs Group Inc. acquired a new stake in shares of Microbot Medical during the first quarter worth approximately $57,000. Renaissance Technologies LLC acquired a new stake in shares of Microbot Medical during the fourth quarter worth approximately $118,000. Finally, Geode Capital Management LLC lifted its stake in Microbot Medical by 7.9% in the fourth quarter. Geode Capital Management LLC now owns 142,659 shares of the biotechnology company's stock valued at $160,000 after acquiring an additional 10,442 shares during the last quarter. 16.30% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
MBOT has been the topic of several research reports. HC Wainwright reissued a "buy" rating and set a $9.00 price objective on shares of Microbot Medical in a research report on Thursday, April 10th. Wall Street Zen raised shares of Microbot Medical from a "sell" rating to a "hold" rating in a report on Saturday, June 14th.
Check Out Our Latest Analysis on Microbot Medical
Microbot Medical Company Profile
(
Get Free Report)
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
See Also
Before you consider Microbot Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microbot Medical wasn't on the list.
While Microbot Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
